Atara Biotherapeutics Inc (NASDAQ: ATRA)

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. Take a look at the 1-year chart of Atara (NASDAQ: ATRA) with the added notations: ATRA has a key level of support at $35 (green). The stock looks like its probably making its… Continue Reading »